First Affiliated Hospital of Harbin Medical University
First Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Recruiting | Phase 2 | 2026-09-01 | NCT07796516 | |
| PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke | Arterial Occlusive Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Atherosclerotic, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, vascular disorder | Not yet recruiting | Phase 4 | 2026-07-15 | NCT07466251 | |
| PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis | Arterial Occlusive Diseases, Intracranial Atherosclerosis, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Atherosclerotic, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, vascular disorder | Recruiting | Phase 4 | 2026-06-12 | NCT06902740 | |
| Rapid dFLC Response Predict CHR in AL Amyloidosis | Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, primary systemic amyloidosis, proteostasis deficiencies | Recruiting | Not stated | 2026-03-09 | NCT06627309 | |
| Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation | Cardiovascular Events; Hematopoietic Stem Cell Transplantation; Transplant Complication | Recruiting | Not stated | 2026-01-16 | NCT07349498 |